UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

The lancet oncology, 2021-03, Vol.22 (3), p.321-331

2021

Volltextzugriff (PDF)

Dexrazoxane for the treatment of chemotherapy-related side effects

Cancer management and research, 2014-01, Vol.6 (default), p.357-363

Langer, Seppo W

2014

Volltextzugriff (PDF)

Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-04, Vol.166, p.49-57

2022

Volltextzugriff (PDF)

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

Annals of oncology, 2007-03, Vol.18 (3), p.546-550

2007

Volltextzugriff (PDF)

A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis

Annals of oncology, 2007-02, Vol.18 (2), p.338-345

2007

Volltextzugriff (PDF)

Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

British Journal of Cancer, 1999-05, Vol.80 (3-4), p.412-418

1999

Volltextzugriff (PDF)

Treatment of Anthracycline Extravasation with Dexrazoxane

Clinical cancer research, 2000-09, Vol.6 (9), p.3680-3686

2000

Volltextzugriff (PDF)

Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone

Cancer chemotherapy and pharmacology, 2006, Vol.57 (1), p.125-128

2006

Volltextzugriff (PDF)

Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

Annals of oncology, 2001-03, Vol.12 (3), p.405-410

2001

Volltextzugriff (PDF)

Maleimide Is a Potent Inhibitor of Topoisomerase II in Vitro and in Vivo: A New Mode of Catalytic Inhibition

Molecular pharmacology, 2002-05, Vol.61 (5), p.1235-1243

2002

Volltextzugriff (PDF)

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

Supportive care in cancer, 2007-04, Vol.15 (4), p.417-426

2007

Volltextzugriff (PDF)

Dexrazoxane in anthracycline extravasation

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3064

2000

Volltextzugriff (PDF)

THE 6-MINUTE WALK TEST AS A PRE-TREATMENT PREDICTOR FOR ADVERSE EVENTS IN PATIENTS WITH LUNG CANCER: A FEASIBILITY STUDY

Journal of cancer rehabilitation, 2021-09, Vol.4 (1), p.91-96

2021

Volltextzugriff (PDF)

Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

Cancer chemotherapy and pharmacology, 2003-08, Vol.52 (2), p.167-174

2003

Volltextzugriff (PDF)

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent

Cancer chemotherapy and pharmacology, 2004, Vol.53 (1), p.91-93

2004

Volltextzugriff (PDF)

Inhibitors of Topoisomerase II as pH-dependent Modulators of Etoposide-mediated Cytotoxicity

Clinical cancer research, 1999-10, Vol.5 (10), p.2899-2907

1999

Volltextzugriff (PDF)

Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

Cancer treatment reviews, 1999-12, Vol.25 (6), p.377-386

1999

Volltextzugriff (PDF)

Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation

Lung cancer (Amsterdam, Netherlands), 1996-09, Vol.15 (2), p.171-181

1996

Volltextzugriff (PDF)

Asbestos-induced lung injury among danish jewelry workers

American journal of industrial medicine, 1994-12, Vol.26 (6), p.755-758

1994

Volltextzugriff (PDF)

DEXRAZOXANE - A PROMISING ANTIDOTE IN THE TREATMENT OF ACCIDENTAL EXTRAVASATION OF ANTHRACYCLINES

Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2003, Vol.37 (3), p.174-175

2003

Volltextzugriff (PDF)

Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosis

Sarcoidosis, 1995-03, Vol.12 (1), p.42

1995

Volltextzugriff (PDF)

Economic Predictors of Differences in Interview Faking Between Countries: Economic Inequality Matters, Not the State of Economy

Applied psychology, 2021-07, Vol.70 (3), p.1360-1379

2021

Volltextzugriff (PDF)

Explainability as a Non-Functional Requirement

2019 IEEE 27th International Requirements Engineering Conference (RE), 2019, p.363-368

2019

Volltextzugriff (PDF)

Gray Matter N-Acetyl Aspartate Deficits in Secondary Progressive but Not Relapsing-Remitting Multiple Sclerosis

American journal of neuroradiology : AJNR, 2003-11, Vol.24 (10), p.1941-1945

2003

Volltextzugriff (PDF)

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)

The American journal of cardiology, 2005-03, Vol.95 (5), p.611-614

2005

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(29)
Humans
(22)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Female
(16)
Oncology
(16)
Middle Aged
(12)
Aged
(11)
Male
(11)
Pharmacology. Drug Treatments
(11)
Adult
(10)
Chemotherapy
(8)
Antineoplastic Agents
(7)
Extravasation Of Diagnostic And Therapeutic Materials - Drug Therapy
(6)
Pharmacology & Pharmacy
(6)
Dexrazoxane
(5)
Lung Neoplasms - Drug Therapy
(5)
Lung Neoplasms - Pathology
(5)
Topoisomerase Ii Inhibitors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

Dexrazoxane for the treatment of chemotherapy-related side effects

Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis

Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

Treatment of Anthracycline Extravasation with Dexrazoxane

Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone

Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

Maleimide Is a Potent Inhibitor of Topoisomerase II in Vitro and in Vivo: A New Mode of Catalytic Inhibition

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

Dexrazoxane in anthracycline extravasation

THE 6-MINUTE WALK TEST AS A PRE-TREATMENT PREDICTOR FOR ADVERSE EVENTS IN PATIENTS WITH LUNG CANCER: A FEASIBILITY STUDY

Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent

Inhibitors of Topoisomerase II as pH-dependent Modulators of Etoposide-mediated Cytotoxicity

Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation

Asbestos-induced lung injury among danish jewelry workers

DEXRAZOXANE - A PROMISING ANTIDOTE IN THE TREATMENT OF ACCIDENTAL EXTRAVASATION OF ANTHRACYCLINES

Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosis

Economic Predictors of Differences in Interview Faking Between Countries: Economic Inequality Matters, Not the State of Economy

Explainability as a Non-Functional Requirement

Gray Matter N-Acetyl Aspartate Deficits in Secondary Progressive but Not Relapsing-Remitting Multiple Sclerosis

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)

Suchergebnisse filtern